GLOBAL SALES AND R&D

HYDROPONICS CANADA AND U.S.A. LICENSED PRODUCTS AND SALES

INTERNATIONAL INVESTMENTS
AND PARTNERSHIPS

GROW AND IP
BREEDS AND STRAINS

previous arrow
next arrow
Slider

THC has rapidly grown to become Australia’s Leading Medicinal Cannabis Company.

THC operates under a ‘farm to pharma’ pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes. Having secured both a significant growing capacity over two grow sites, and an industry-leading pharmaceuticals biomanufacturing facility, THC is in prime position to service both domestic patients and the export market.

THC’s global commercial partners operate across four continents, supporting THC’s future international growth. THC also operates a revenue generating global hydroponics business, focusing on the manufacturing and distribution of hydroponics equipment, materials, and nutrients.

Medicinal Cannabis

Delivering farm to pharma

Hydroponics

Servicing a growing medicinal cannabis industry

Global Relationships

Media Interview

Latest Media Interview January 2020:

Proactive Investors interview with THC Global Group Limited CEO Mr Ken Charteris

Contact us

Registered Office
Suite 4102,
Level 41 Australia Square
264 George Street
Sydney NSW 2000

 

+61 (0)2 8088 4760

Subscribe To Receive ASX Announcement Updates